Search Results - "de Lau, Lonneke"

Refine Results
  1. 1

    Epidemiology of Parkinson's disease by de Lau, Lonneke M L, Breteler, Monique M B

    Published in Lancet neurology (01-06-2006)
    “…The causes of Parkinson's disease (PD), the second most common neurodegenerative disorder, are still largely unknown. Current thinking is that major gene…”
    Get more information
    Journal Article
  2. 2

    Screening tests for aphasia in patients with stroke: a systematic review by El Hachioui, Hanane, Visch-Brink, Evy G., de Lau, Lonneke M. L., van de Sandt-Koenderman, Mieke W. M. E., Nouwens, Femke, Koudstaal, Peter J., Dippel, Diederik W. J.

    Published in Journal of neurology (01-02-2017)
    “…Aphasia has a large impact on the quality of life and adds significantly to the costs of stroke care. Early recognition of aphasia in stroke patients is…”
    Get full text
    Journal Article Book Review
  3. 3

    Survival in Parkinson's disease. Relation with motor and non-motor features by de Lau, Lonneke M.L, Verbaan, Dagmar, Marinus, Johan, van Hilten, Jacobus J

    Published in Parkinsonism & related disorders (01-06-2014)
    “…Abstract Background Survival in patients with Parkinson's disease is reduced as compared to the general population. We aimed to identify motor and non-motor…”
    Get full text
    Journal Article
  4. 4

    Serum Cholesterol Levels and the Risk of Parkinson's Disease by de Lau, Lonneke M. L., Koudstaal, Peter J., Hofman, Albert, Breteler, Monique M. B.

    Published in American journal of epidemiology (15-11-2006)
    “…Several recent findings suggest a role of lipid and cholesterol metabolism in the pathogenesis of Parkinson's disease. Therefore, the authors examined the…”
    Get full text
    Journal Article
  5. 5

    Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease by de Lau, Lonneke M.L., Verbaan, Dagmar, Marinus, Johan, Heutink, Peter, van Hilten, Jacobus J.

    Published in Movement disorders (01-01-2012)
    “…Background: The A‐allele of the catechol‐O‐methyltransferase (COMT) Val158Met polymorphism is associated with decreased enzymatic activity and higher dopamine…”
    Get full text
    Journal Article
  6. 6

    Serum uric acid levels and the risk of Parkinson disease by de Lau, Lonneke M. L., Koudstaal, Peter J., Hofman, Albert, Breteler, Monique M. B.

    Published in Annals of neurology (01-11-2005)
    “…In a prospective population‐based cohort study among 4,695 participants aged 55 years and older, with repeated in‐person examination and on average 9.4 years…”
    Get full text
    Journal Article
  7. 7

    Validation of a prediction model for long-term outcome of aphasia after stroke by Nouwens, Femke, Visch-Brink, Evy G, El Hachioui, Hanane, Lingsma, Hester F, van de Sandt-Koenderman, Mieke W M E, Dippel, Diederik W J, Koudstaal, Peter J, de Lau, Lonneke M L

    Published in BMC neurology (15-10-2018)
    “…About 30% of stroke patients suffer from aphasia. As aphasia strongly affects daily life, most patients request a prediction of outcome of their language…”
    Get full text
    Journal Article
  8. 8

    Relationship of Von Willebrand Factor with carotid artery and aortic arch calcification in ischemic stroke patients by Sonneveld, Michelle A.H, van Dijk, Anouk C, van den Herik, Evita G, van Loon, Janine E, de Lau, Lonneke M.L, van der Lugt, Aad, Koudstaal, Peter J, de Maat, Moniek P.M, Leebeek, Frank W.G

    Published in Atherosclerosis (01-10-2013)
    “…Abstract Background Large population studies have revealed that increased von Willebrand Factor (VWF) levels are associated with an increased risk of ischemic…”
    Get full text
    Journal Article
  9. 9

    Plasma folate concentration and cognitive performance: Rotterdam Scan Study by Lau, Lonneke ML de, Refsum, Helga, Smith, A. David, Johnston, Carole, Breteler, Monique MB

    Published in The American journal of clinical nutrition (01-09-2007)
    “…BACKGROUND:Evidence is increasing for beneficial and independent effects of folate on cognitive function, but the underlying biologic mechanism is as yet…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Optimal timing of speech and language therapy for aphasia after stroke: more evidence needed by Nouwens, Femke, Visch-Brink, Evy G, Van de Sandt-Koenderman, Mieke M E, Dippel, Diederik W J, Koudstaal, Peter J, de Lau, Lonneke M L

    Published in Expert review of neurotherapeutics (03-08-2015)
    “…Aphasia due to stroke affects communication and quality of life. Most stroke survivors with aphasia receive speech and language therapy. Although an early…”
    Get more information
    Journal Article
  12. 12

    Genetic variation in homocysteine metabolism, cognition, and white matter lesions by de Lau, Lonneke M.L, van Meurs, Joyce B.J, Uitterlinden, André G, Smith, A. David, Refsum, Helga, Johnston, Carole, Breteler, Monique M.B

    Published in Neurobiology of aging (01-11-2010)
    “…Abstract Several studies have shown an association between homocysteine concentration and cognitive performance or cerebral white matter lesions. However,…”
    Get full text
    Journal Article
  13. 13

    Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors by Van Schaik, Sander M., Scott, Saskia, de Lau, Lonneke M.L., Van den Berg-Vos, Renske M., Kruyt, Nyika D.

    Published in Cerebrovascular diseases extra (12-06-2015)
    “…Background: The clinical benefit of intravenous thrombolysis (IVT) in acute ischemic stroke is time dependent. Several studies report a short median…”
    Get full text
    Journal Article
  14. 14

    Rotterdam Aphasia Therapy Study (RATS)-3: "The efficacy of intensive cognitive-linguistic therapy in the acute stage of aphasia"; design of a randomised controlled trial by Nouwens, Femke, Dippel, Diederik Wj, de Jong-Hagelstein, Marjolein, Visch-Brink, Evy G, Koudstaal, Peter J, de Lau, Lonneke M L

    Published in Trials (23-01-2013)
    “…Aphasia is a severely disabling condition occurring in 20 to 25% of stroke patients. Most patients with aphasia due to stroke receive speech and language…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    γ'/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke by van den Herik, Evita G, Cheung, Elim Y L, de Lau, Lonneke M L, den Hertog, Heleen M, Leebeek, Frank W, Dippel, Diederik W J, Koudstaal, Peter J, de Maat, Moniek P M

    Published in Thrombosis and haemostasis (01-03-2011)
    “…Fibrinogen γ' (γ') is a natural isoform of fibrinogen, and alters the rate of formation and the properties of clots. It could therefore affect outcome after…”
    Get more information
    Journal Article
  18. 18

    Methylenetetrahydrofolate reductase C677T genotype and PD by de Lau, Lonneke M. L., Koudstaal, Peter J., van Meurs, Joyce B. J., Uitterlinden, André G., Hofman, Albert, Breteler, Monique M. B.

    Published in Annals of neurology (01-06-2005)
    “…In a prospective, population‐based cohort study among 5,920 participants aged 55 years or older, we observed that the TT variant of the…”
    Get full text
    Journal Article
  19. 19

    Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease by Bornebroek, Marjolijn, de Lau, Lonneke M L, Haag, Mendel D M, Koudstaal, Peter J, Hofman, Albert, Stricker, Bruno H C, Breteler, Monique M B

    Published in Neuroepidemiology (01-01-2007)
    “…Several lines of evidence suggest a role of inflammatory processes in Parkinson disease, although it is still unclear whether inflammation is a cause or rather…”
    Get more information
    Journal Article
  20. 20